New antimicrobials on the horizon / 대한내과학회지
Korean Journal of Medicine
; : 35-51, 2009.
Article
in Ko
| WPRIM
| ID: wpr-163505
Responsible library:
WPRO
ABSTRACT
Recently, infections caused by antibiotic-resistant bacteria continue to climb in the community and the hospital around the world. Our current antimicrobial agents are gradually becoming ineffective and a new pipeline of powerful compounds is needed urgently. A number of new antimicrobial compounds are in development, including novel glycopeptides (dalbavancin, telavancin, and oritavancin), daptomycin, tigecycline, ceftobiprole, iclaprim, and doripenem. The article will provide an update on the newly marketed and potentially effective antibacterial agents in the late-stage development pipeline
Key words
Full text:
1
Index:
WPRIM
Main subject:
Pyrimidines
/
Bacteria
/
Drug Resistance
/
Glycopeptides
/
Carbapenems
/
Drugs, Investigational
/
Cephalosporins
/
Daptomycin
/
Trastuzumab
/
Aminoglycosides
Language:
Ko
Journal:
Korean Journal of Medicine
Year:
2009
Type:
Article